Antigua and Barbuda vs Lebanon: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Lebanon
100.0%
in 2024
Antigua and Barbuda rank
1st
Lebanon rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Lebanon
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Lebanon, a difference of 0.0%.
Across all 5 years both countries report, Lebanon has been ahead every year.
Antigua and Barbuda ranks 1st and Lebanon ranks 1st of 144 countries.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Lebanon?
- Antigua and Barbuda, at 100.0% against 100.0% in Lebanon as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Lebanon?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Lebanon?
- 5 years are reported by both, from 2010 to 2014.
- How do Antigua and Barbuda and Lebanon rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Lebanon ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.